Publications by authors named "Suzanne Fuqua"

Claim this Profile
D
Discovery of a novel small molecule degrader of wild type and mutant estrogen receptors using DNA encoded libraries.
Anil Kumar Devakrishnan, Chandrashekhar Madasu, Yong Wang, Ramkumar Modukuri, Kurt M Bohren, Suzanne A W Fuqua

NPJ Breast Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer.
Derek Dustin, Guowei Gu, Amanda R Beyer, Sarah K Herzog, David G Edwards, Suzanne A W Fuqua

Br J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adipocyte/Tumor cell crosstalk via IGF-1/TXNIP axis promotes malignancy and endocrine resistance in breast cancer.
Amanda Caruso, Felice Maria Accattatis, Cinzia Giordano, Luca Gelsomino, Piercarlo Del Console, Suzanne A W Fuqua

Cell Commun Signal· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence that CRISPR-Cas9 Y537S-mutant expressing breast cancer cells activate Yes-associated protein 1 to driving the conversion of normal fibroblasts into cancer-associated fibroblasts.
Luca Gelsomino, Amanda Caruso, Emine Tasan, Adele Elisabetta Leonetti, Rocco Malivindi, Suzanne A W Fuqua

Cell Commun Signal· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer.
Anran Chen, Beom-Jun Kim, Aparna Mitra, Craig T Vollert, Jonathan T Lei, Suzanne A W Fuqua

Mol Cancer Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial Expression of Concern: Role of BRCA1 in heat shock response.
Yong Xian Ma, Saijun Fan, Jingbo Xiong, Ren-Qi Yuan, Qinghui Meng, Suzanne A Fuqua

Oncogene· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incongruity between T cell receptor recognition of breast cancer hotspot mutations ESR1 Y537S and D538G following exogenous peptide loading versus endogenous antigen processing.
Paul Shafer, Wingchi K Leung, Mae Woods, Jong Min Choi, Carlos M Rodriguez-Plata, Suzanne Fuqua

Cytotherapy· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolomic Rewiring Promotes Endocrine Therapy Resistance in Breast Cancer.
Songyeon Ahn, Jun Hyoung Park, Sandra L Grimm, Danthasinghe Waduge Badrajee Piyarathna, Tagari Samanta, Suzanne A W Fuqua

Cancer Res· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ESR1 mutations and therapeutic resistance in metastatic breast cancer: progress and remaining challenges.
Sarah K Herzog, Suzanne A W Fuqua

Br J Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Hormonal modulation of ESR1 mutant metastasis.
Guowei Gu, Lin Tian, Sarah K Herzog, Yassine Rechoum, Luca Gelsomino, Suzanne A W Fuqua

Oncogene· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastasis: complexity thwarts precision targeting.
Suzanne A W Fuqua

Br J Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hormonal modulation of ESR1 mutant metastasis.
Guowei Gu, Lin Tian, Sarah K Herzog, Yassine Rechoum, Luca Gelsomino, Suzanne A W Fuqua

Oncogene· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer.
Derek Dustin, Guowei Gu, Amanda R Beyer, Sarah K Herzog, David G Edwards, Suzanne A W Fuqua

Br J Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leptin Signaling Contributes to Aromatase Inhibitor Resistant Breast Cancer Cell Growth and Activation of Macrophages.
Luca Gelsomino, Cinzia Giordano, Giusi La Camera, Diego Sisci, Stefania Marsico, Suzanne Fuqua

Biomolecules· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen-induced transcription at individual alleles is independent of receptor level and active conformation but can be modulated by coactivators activity.
Fabio Stossi, Radhika D Dandekar, Maureen G Mancini, Guowei Gu, Suzanne A W Fuqua

Nucleic Acids Res· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ESR1 mutations in breast cancer.
Derek Dustin, Guowei Gu, Suzanne A W Fuqua

Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of ESR1 Mutations on the Treatment of Metastatic Breast Cancer.
Sasha M Pejerrey, Derek Dustin, Jin-Ah Kim, Guowei Gu, Yassine Rechoum, Suzanne A W Fuqua

Horm Cancer· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Notch-1-PTEN-ERK1/2 signaling axis promotes HER2+ breast cancer cell proliferation and stem cell survival.
Andrew Baker, Debra Wyatt, Maurizio Bocchetta, Jun Li, Aleksandra Filipovic, Suzanne Fuqua

Oncogene· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic profiling identifies key coactivators utilized by mutant ERα proteins as potential new therapeutic targets.
Leah A Gates, Guowei Gu, Yue Chen, Aarti D Rohira, Jonathan T Lei, Suzanne A W Fuqua

Oncogene· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer.
Mothaffar F Rimawi, Carmine De Angelis, Alejandro Contreras, Fresia Pareja, Felipe C Geyer, Suzanne A W Fuqua

Breast Cancer Res Treat· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrophages promote the progression of premalignant mammary lesions to invasive cancer.
Emily C Carron, Samuel Homra, Jillian Rosenberg, Seth B Coffelt, Frances Kittrell, Suzanne A Fuqua

Oncotarget· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: ESR1 mutations affect anti-proliferative responses to tamoxifen through enhanced cross-talk with IGF signaling.
Luca Gelsomino, Guowei Gu, Yassine Rechoum, Amanda R Beyer, Sasha M Pejerrey, Suzanne A W Fuqua

Breast Cancer Res Treat· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapy for breast cancer and molecular mechanisms of resistance to treatment.
Guowei Gu, Derek Dustin, Suzanne Aw Fuqua

Curr Opin Pharmacol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ESR1 Mutations in Cell-Free DNA of Breast Cancer: Predictive "Tip of the Iceberg".
Suzanne A W Fuqua, Yassine Rechoum, Guowei Gu

JAMA Oncol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumour and cellular distribution of activated forms of PR in breast cancers: a novel immunohistochemical analysis of a large clinical cohort.
Jacques Bonneterre, Jacques Bosq, Philippe Jamme, Alexander Valent, Erard M Gilles, Suzanne A W Fuqua

ESMO Open· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis